SCHEMBL6985778

SCHEMBL6985778

CCOC(=O)CN(c1ccc2c(c1)CCCN2C(=O)CCc1ccc(C(=N)N)cc1)S(=O)(=O)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 4/20 0.43
USP2 O75604 2/20 0.43
MAPK1 P28482 1/20 0.43
POLB P06746 1/20 0.42
LMNA P02545 1/20 0.41
PDK1 Q15118 1/20 0.41
PDK2 Q15119 1/20 0.41
PDK3 Q15120 1/20 0.41
PDK4 Q16654 1/20 0.41
GAA P10253 1/20 0.40
ALDH1A1 P00352 2/20 0.39
F2 P00734 2/20 0.39
F10 P00742 1/20 0.39
HPGD P15428 2/20 0.39
HTT P42858 1/20 0.39
TSHR P16473 1/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7958935 0.92 F10 (0.41) NR3C1POLBPDK1PDK2PDK3
SCHEMBL6982322 0.90 NR3C1 (0.47) NR3C1POLBALDH1A1F2HPGD
SCHEMBL6979171 0.90 USP2 (0.41) NR3C1USP2MAPK1POLBLMNA
Iodide SCHEMBL7960633 0.90 F2 (0.41) NR3C1POLBPDK1PDK2PDK3
Hydrochloric Acid SCHEMBL6979622 0.89 F2 (0.39) NR3C1POLBPDK1PDK2PDK3
SCHEMBL6987763 0.88 NR3C1 (0.47) NR3C1USP2MAPK1POLBLMNA
SCHEMBL7405916 0.87 NR3C1 (0.46) NR3C1POLBLMNAPDK1PDK2
Hydrochloric Acid SCHEMBL6984704 0.86 NR3C1 (0.49) NR3C1POLBLMNAGAAALDH1A1
SCHEMBL6979175 0.86 USP2 (0.39) NR3C1USP2MAPK1POLBLMNA
Iodide SCHEMBL7949045 0.86 NR3C1 (0.46) NR3C1POLBLMNAPDK1PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0991624-B1 PHENYLALKYL DERIVATIVES WITH THROMBIN-INHIBITING EFFECT BOEHRINGER INGELHEIM PHARMA (DE) 2003-11-19 EP claimed
US-6300342-B1 FOR THERAPY OR INHIBITING THROMBUS FORMATION; FOR THERAPY OF FIBRIN-DEPENDENT INFLAMMATORY CONDITION BOEHRINGER INGELHEIM PHARM KG (DE) 2001-10-09 US disclosed